Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B

OBJECTIVE: The aims of this study were to investigate the kinetic changes of serum, virological, and immunological markers during entecavir (ETV) antiviral therapy and to explore whether these indicators can predict the antiviral efficacy of ETV in hepatitis B e antigen (HBeAg)-positive chronic hepa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Minghui, Gao, Yuanjiao, Yang, Liu, Lin, Yanjie, Deng, Wen, Jiang, Tingting, Bi, Xiaoyue, Lu, Yao, Zhang, Lu, Shen, Ge, Liu, Ruyu, Wu, Shuling, Chang, Min, Xu, Mengjiao, Hu, Leiping, Song, Rui, Jiang, Yuyong, Yi, Wei, Xie, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531241/
https://www.ncbi.nlm.nih.gov/pubmed/36203581
http://dx.doi.org/10.3389/fimmu.2022.1024333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9531241/
https://www.ncbi.nlm.nih.gov/pubmed/36203581
http://dx.doi.org/10.3389/fimmu.2022.1024333

Ejemplares similares